| Catalyst | Drug/Treatment | Stage | Probability of Approval | Description | Drug Type | Therapeutic Area | Source |
|---|---|---|---|---|---|---|---|
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology | ||
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology | ||
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology |
Recent Updates
Recently added Catalysts
Retractable Technologies, Inc.
$0.69
+0 (+0.18%)
Market Cap
20.73 M
EPS
-0.21
P/E Ratio
-
Value Trade
16.38 K
3.36 %
Week
-3.82 %
1 Month
8.2 %
3 Month
4.77 %
6 Month
-92.78 %
5 Year
-87.04 %
All Time
Cash Data
Cash Position
-
Monthly Burn
-
Runway
-
Overview
Volume
44.96 K
52 Week Range
0.60 - 1.14
% held by Insiders
59.23 %
% held by Institutions
8.26 %
Enterprise Value
17.97 M
Total Shares
29.92 M
Short %
0.19 %
Float Shares
12.21 M
Company Description
locked
Upcoming Catalyst
Past FDA Catalysts & PDUFA Decisions
| Date | Drug | Catalyst | Stage | Outcome | Reaction | Event Move % | Best Trade % |
|---|---|---|---|---|---|---|---|
— | Example Drug | Phase 3 data readout | Phase 3 | — | – | 0% | 0% |
— | Example Drug | Phase 3 data readout | Phase 3 | — | – | 0% | 0% |
— | Example Drug | Phase 3 data readout | Phase 3 | — | – | 0% | 0% |
Drug Pipeline Intelligence
RVP Clinical Trial Results & History
| Drug Name | Indications | Phase | Date | Trial Results Summary | Title | Source |
|---|---|---|---|---|---|---|
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | The study met its primary endpoint demonstrating statistically significant improvement. Read More | Phase 3 Study Results Announcement | |
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | The study met its primary endpoint demonstrating statistically significant improvement. Read More | Phase 3 Study Results Announcement | |
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | The study met its primary endpoint demonstrating statistically significant improvement. Read More | Phase 3 Study Results Announcement |
Inside Trades
YEARLY INSIDER TRANSACTIONS
Sector Avg.
INSIDERS
SOLDINSIDERS
BOUGHT
SOLDINSIDERS
BOUGHT
POSITIVE SENTIMENT Based on 22 Insiders Transactions
Hedge Funds
Shares Held
HEDGE FUNDS
SOLDHEDGE FUNDS
BOUGHT
SOLDHEDGE FUNDS
BOUGHT
POSITIVE SENTIMENT Based on 27 hedge funds in the last quarter
18 buying (3 new)·9 selling (1 exited)·2 unchanged
Hedge Funds invested in RVP
| HedgeFund Name ( 3 ) | % of Portfolio | Current MV - | Shares Owned - | Activity Avg Price $0 |
|---|---|---|---|---|
Example Capital Management | 2.5 % | 15.00 M | 250.00 K | |
Example Capital Management | 2.5 % | 15.00 M | 250.00 K | |
Example Capital Management | 2.5 % | 15.00 M | 250.00 K |
RVP Institutional Ownership Trends
Current Insider %
5.20%
—+0.00%
Current Institutional %
62.40%
—+0.00%
Total Ownership
67.60%
Insider + Institutional
Data Points
1
1 Ticker(s)
Option Chain Statistics
| Expiration | Volume | Open Interest | Implied Volatility Calls | Implied Volatility Puts | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Calls | Puts | Put-Call Ratio | Calls | Puts | Put-Call Ratio | IV | OiWaIv | VWaIv | IV | OiWaIv | VWaIv | |
| 2026-09-18 | 0 | 0.00 | 0 | 0 | - | - | - | - | - | - | ||
| 2026-09-18 | 0 | 0.00 | 0 | 0 | - | - | - | - | - | - | ||
| 2026-09-18 | 0 | 0.00 | 0 | 0 | - | - | - | - | - | - | ||
Option Chain
| Calls | Strike | Puts | ||||
|---|---|---|---|---|---|---|
| Last Price | Volume | Open Interest | Last Price | Volume | Open Interest | |
| No data available | ||||||
Open interest
Today's Open Interest
1.00 M
Put-Call Ratio
1.1
Put Open Interest
480.00 K
Call Open Interest
520.00 K
Open Interest Avg (30-day)
900,000
Today vs Open Interest Avg (30-day)
11.11%
Option Volume
Today's Volume
750.00 K
Put-Call Ratio
0.95
Put Volume
360.00 K
Call Volume
390.00 K
Volume Avg (30-day)
800,000
Today vs Volume Avg (30-day)
-6.25%
Company News
RVP▲ +0.2%today
Retractable Technologies, Inc. Results for the Periods Ended June 30, 2026
Retractable Technologies, Inc. reported a decline in net sales for the second quarter of 2026, totaling $7.2 million, down from $10.4 million in the same period last year. The company also experienced an operating loss of $5.1 million, consistent with the previous year. For the first half of 2026, net sales were $14.4 million, compared to $18.7 million in 2025, indicating ongoing financial challenges.
Read more →RVPRetractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock Shareholders
Retractable Technologies, Inc. has announced dividends for its Series II and III Class B preferred stock shareholders. This declaration reflects the company's commitment to returning value to its investors. Further details about the dividend amounts and payment dates were not provided in the announcement.
Read more →RVP▼ -7.3%on this news
RETRACTABLE TECHNOLOGIES, INC. RESULTS FOR THE PERIOD ENDED MARCH 31, 2026
Retractable Technologies, Inc. reported total net sales of $7.2 million for the first quarter of 2026, a decline from $8.3 million in the same period last year. The company experienced an operating loss of $6.2 million compared to $4.7 million the previous year, influenced by increased operating expenses and a significant reduction in domestic sales. Despite a rise in international sales driven by EasyPoint needle sales, overall revenues fell due to decreased selling prices and a negative gross margin. Additionally, the workforce was reduced by approximately 16% to save costs.
Read more →RVP▼ -6.7%on this news
Retractable Technologies, Inc. Announces Workforce Reduction
Retractable Technologies, Inc. has announced a 16% workforce reduction aimed at saving approximately $2.2 million in annual costs. This decision is part of the company's strategy to enhance domestic production and reduce reliance on imports from China, particularly in light of tariff impacts. While the move is expected to improve efficiency, it also involves one-time separation payments for affected employees.
Read more →RVP▲ +5.5%on this newsshared move
RETRACTABLE TECHNOLOGIES
Retractable Technologies, Inc. has announced a significant workforce reduction of about 16%, aimed at saving approximately $2.2 million in annual costs. This move is part of the company's strategy to enhance domestic manufacturing capabilities and mitigate reliance on Chinese imports, largely influenced by tariffs. Although the reduction will help cut costs, it also brings about one-time separation payments to affected workers and continues the company's dependence on imports for certain products.
Read more →RVPRETRACTABLE TECHNOLOGIES, INC. REPORTS RESULTS FOR 2025
Retractable Technologies, Inc. reported a 15.8% increase in revenues for the year 2025, reaching approximately $38.3 million. Significant growth in international sales, particularly for EasyPoint needles, contributed to this rise. However, the company also faced high operating costs and incurred losses from operations totaling $21.2 million, similar to the previous year’s results. The ongoing impact of tariffs, particularly a 120% rate on imported products from China, creates uncertainty for future operations and financial stability.
Read more →RVPA Physician Assistant’s Viral Needlestick Injury
In December 2023, a physician assistant experienced a needlestick injury while administering an injectable HIV medication. Despite following safety protocols, the incident shook their confidence and highlighted the human aspect of healthcare. The assistant emphasized the importance of discussing such accidents openly and adhering to safety measures to prevent future occurrences.
Read more →RVPA Moment You Never Forget
The article recounts a nurse's personal experience with a needlestick injury while performing an endoscopic fine needle aspiration in 1999. Despite using advanced equipment and following protocols, the incident raised concerns about safety in healthcare. The author emphasizes that while the statistical risk of infection is low, the fear of exposure remains significant among healthcare workers, as many have faced similar experiences.
Read more →RVPTalking to Your Team About Prevention
The article discusses the ongoing issue of needlestick injuries among healthcare workers, emphasizing the need for open conversations about safety without blame. It highlights the importance of understanding systemic factors contributing to these injuries and encourages collaboration among staff to improve safety practices. The piece also underscores the role of device design in preventing injuries and calls for a cultural shift towards proactive safety discussions.
Read more →RVPRETRACTABLE TECHNOLOGIES, INC. DECLARES DIVIDENDS TO SERIES II AND III CLASS B
Retractable Technologies, Inc. has announced the declaration of dividends for its Series II and III Class B Preferred Stock shareholders, amounting to $39,050.00 and $18,561.25 respectively. These dividends, accruing at $1.00 per share per annum, cover the period from October 1 to December 31, 2025, and are set to be paid on January 20, 2026, to shareholders recorded by January 10, 2026. This announcement highlights the company's ongoing commitment to providing returns to its investors amidst its operational initiatives in safety medical products.
Read more →RVPHow a Needlestick Changed Me Forever
The article recounts a nurse's traumatic experience following a needlestick injury, highlighting the emotional and psychological impacts of such incidents. The author reflects on the lessons learned about advocating for safety, the importance of colleague support, and the necessity of patience. Ultimately, the experience fostered personal growth and a renewed commitment to nursing despite the challenges faced.
Read more →RVPRetractable Technologies, Inc. Receives Innovative Technology Designation from Vizient for EasyPoint Blood Collection Tube Holder with Needle
Retractable Technologies, Inc. has announced that its EasyPoint Blood Collection Tube Holder with Needle has received an Innovative Technology designation from Vizient. This recognition highlights the product's potential to enhance patient and healthcare worker safety by reducing needlestick injuries. The device is designed for ease of use and efficiency, demonstrating the company's commitment to innovation in healthcare.
Read more →RVPRETRACTABLE TECHNOLOGIES, INC. RESULTS FOR THE PERIODS ENDED SEPTEMBER 30, 2025
Retractable Technologies, Inc. reported total net sales of $10.1 million and an operating loss of $3.7 million for Q3 2025, reflecting a modest improvement compared to the prior year's results. The company continues to face challenges due to high tariffs on imported products, which have materially affected its operational costs. Despite the difficulties, there has been a reduction in overall operating losses, and international revenues saw an increase. Moving forward, efforts to shift production to domestic facilities are ongoing to mitigate tariff impacts.
Read more →RVPRetractable Technologies Welcomes Congressional Leaders to Highlight Texas Innovation and U.S. Supply Chain Readiness
Retractable Technologies, Inc. hosted Texas congressional leaders to showcase its efforts in enhancing domestic manufacturing of medical devices. The visit emphasized the company's commitment to protecting healthcare workers and strengthening the U.S. supply chain, with over $138 million invested since the COVID-19 pandemic. CEO Thomas Shaw highlighted the importance of collaboration between policy and industry.
Read more →RVPRETRACTABLE TECHNOLOGIES, INC. RESULTS FOR THE PERIODS ENDED JUNE 30, 2025
Retractable Technologies, Inc. reported total net sales of $10.4 million for Q2 2025, up from $6.0 million in Q2 2024, but also recorded a higher operating loss of $5.1 million. Tariffs imposed on imports from China continue to heavily affect the company's financial performance, prompting a shift toward more U.S.-based production. Moreover, sales of the EasyPoint needle contributed positively to revenues, but a decrease in average selling price due to product mix changes was noted. The company also reported a net loss for the first six months of the year totaling $10.6 million, including an unrealized loss on investments of $5.6 million, although they received a $1.9 million settlement in the second quarter.
Read more →RVPRETRACTABLE TECHNOLOGIES, INC. RESULTS FOR THE PERIOD ENDED MARCH 31, 2025
Retractable Technologies, Inc. reported total net sales of $8.3 million for Q1 2025, marking an increase from $7.6 million in Q1 2024. However, the company experienced a higher operating loss of $4.7 million, attributed to rising tariffs and increased production costs, which also contributed to a significant unrealized loss on investments. Domestic sales represented a strong 89.6% of total revenues, with unit sales up by 18.9%, although average selling prices faced pressure due to shifts in product mix. The ongoing challenges from tariffs are anticipated to impact future profitability.
Read more →RVPRetractable Technologies, Inc. Announces Reduction in Workforce
Retractable Technologies, Inc. has announced a 7% reduction in its workforce, aiming to save approximately $1.6 million in annual costs. This decision is part of a broader strategy to enhance U.S. manufacturing capabilities and reduce reliance on Chinese products due to tariff impacts. The company will incur one-time separation payments totaling around $300 thousand for affected employees.
Read more →RVPRETRACTABLE TECHNOLOGIES, INC. REPORTS RESULTS FOR 2024
Retractable Technologies, Inc. reported a significant decline in revenues for 2024, falling by 24.2% to approximately $33 million. The company experienced notable domestic and international revenue losses, with domestic sales down by 15.1% and international sales dropping by 59.1%. Operating costs have risen, contributing to an increased loss from operations of $21.1 million. Additionally, the company faces challenges related to tariffs and the potential financial impact of recent legislative measures involving oil imports.
Read more →RVPCongressional Visit
Retractable Technologies, Inc. (RTI) hosted a congressional visit featuring staff from Senators Cornyn and Cruz, along with local leaders. The tour showcased RTI's advanced syringe manufacturing processes, emphasizing the importance of a robust domestic supply chain for public health. Discussions focused on federal policies supporting small businesses and RTI's commitment to American-made medical devices.
Read more →RVPAfrican-American Trailblazers in Nursing
Retractable Technologies honors African American nurses who have significantly impacted healthcare, including Mary Eliza Mahoney, Harriet Tubman, Goldie D. Brangman-Dumpson, and Adah Belle Thoms. These trailblazers overcame barriers and established organizations that paved the way for future generations. Their contributions have shaped a more inclusive healthcare system.
Read more →RVPRetractable Technologies, Inc. Withdraws Complaint in United States Court of International Trade
Retractable Technologies, Inc. has withdrawn its complaint regarding a 100% tariff on syringes and needles imported from China, leading to the case's dismissal. Despite the challenges posed by the tariffs, RTI has adapted its production processes to reduce reliance on imports. Management acknowledges the difficulties of competing against larger corporations in the current market environment.
Read more →RVP▼ -8.4%on this newsshared move
Addressing the Ongoing Challenge of Sharps Injuries: A Commitment to Workplace Safety
Retractable Technologies, Inc. (RTI) addresses the ongoing challenge of sharps injuries among healthcare workers, emphasizing the need for improved safety protocols and device adoption. Despite advancements, the rate of needlestick injuries remains steady, highlighting the urgency for a cultural shift in healthcare practices. RTI advocates for better regulations and promotes a safer working environment for healthcare professionals.
Read more →RVP▼ -9.5%on this news
RETRACTABLE TECHNOLOGIES, INC. RESULTS FOR THE PERIODS ENDED SEPTEMBER 30, 2024
Retractable Technologies, Inc. reported total net sales of $10.3 million for the third quarter of 2024, showing no growth compared to the previous year. However, the company experienced a significant operating loss of $5.1 million, worsening from a loss of $936 thousand in Q3 2023. The decline in revenues is attributed to falling average selling prices and a substantial drop in international sales. The company also faces increasing costs due to new tariffs imposed on imported syringes from China, which have led to ongoing financial challenges.
Read more →RVPRetractable Technologies, Inc. Files Complaint in United States Court of International Trade
Retractable Technologies, Inc. has filed a complaint in the U.S. Court of International Trade against a 100% tariff on syringes and needles from China. The company seeks preliminary injunctions and a decision to set aside the tariffs, citing potential irreparable harm. The complaint details procedural issues in the tariff review process since 2018.
Read more →RVP▼ -13.3%on this news
Tariffs Finalized on Chinese Imports
Retractable Technologies, Inc. faces severe challenges due to the U.S. Trade Representative's decision to impose a 100% tariff on Chinese syringes and needles, effective September 27, 2024. This abrupt increase in costs is expected to negatively impact the company's financial stability and operations, potentially leading to layoffs and reduced product availability. Despite efforts to enhance domestic production, immediate reliance on imports remains necessary.
Read more →RVPMedical Conversations
The article discusses the severe impact of diagnostic errors in the U.S., estimating over 795,000 deaths or disabilities each year. It emphasizes the importance of effective communication between patients and healthcare providers to address concerns adequately. The tragic case of Congresswoman Eddie Bernice Johnson illustrates the consequences of medical negligence and the need for better staffing and proactive care in healthcare settings.
Read more →RVP3 Nurses in American History
The article celebrates three influential nurses in American history: Clara Barton, Lillian Wald, and Elizabeth Forster. Each made remarkable contributions to public health and social justice, from founding the American Red Cross to advocating for immigrant rights and integrating traditional practices into healthcare. Their legacies continue to impact healthcare and community welfare today.
Read more →RVPHow To Fight Climate Change From Inside The Hospital
The article discusses the role of healthcare professionals in combating climate change, emphasizing the importance of sustainability within hospitals. It highlights a study showing nurses' awareness of climate change's impact on health and suggests that small, cost-effective changes can lead to significant environmental benefits. The article advocates for healthier dietary options in hospitals to reduce carbon emissions and improve patient health.
Read more →RVPAn Ideal Career For Any Age
Shawn Chastka, who began her nursing career at 42, shares her journey from pharmacy technician to nurse. Despite the challenges posed by the COVID-19 pandemic, including high burnout and personal loss, she remains optimistic and encourages others to pursue nursing. Shawn plans to become a travel nurse in the future as many of her colleagues leave the profession.
Read more →RVPRetractable Technologies, Inc. Results for the Periods Ended June 30, 2024
Retractable Technologies, Inc. reported a decline in net sales and increased operating losses for the second quarter and first half of 2024 compared to the previous year. The company faced challenges due to lower domestic demand and a significant drop in international vaccination-related sales. Proposed tariffs on imported syringes from China could further impact financial results. The company is exploring options to mitigate the financial effects of these tariffs.
Read more →RVPRETRACTABLE TECHNOLOGIES, INC. RESULTS FOR THE PERIODS ENDED JUNE 30, 2024
Retractable Technologies, Inc. has reported a decline in total net sales and an increase in operating losses for the periods ended June 30, 2024. Total net sales fell to $6.0 million compared to $8.0 million in the previous year, with a cumulative loss of $14.2 million for the second quarter. The company faces challenges due to potential tariffs on syringes and needles imported from China, which could significantly impact financial results. Additionally, changes in valuation allowances on deferred tax assets could limit future tax benefits.
Read more →RVPRETRACTABLE TECHNOLOGIES, INC. RESULTS FOR THE PERIOD ENDED MARCH 31, 2024
Retractable Technologies, Inc. reported significant declines in net sales and an operating loss for Q1 2024, largely due to reduced international syringe sales linked to COVID-19 vaccinations. The company's net sales fell to $7.6 million from $11.0 million compared to the same period last year, alongside an increased operating loss of nearly $3.0 million. While domestic revenue showed some growth with a 22.5% increase, the outlook is tempered by a potential 50% tariff on syringes imported from China and uncertain international demand. The overall financial position reflects ongoing challenges following strong growth during the pandemic.
Read more →RVPRETRACTABLE TECHNOLOGIES, INC. REPORTS RESULTS FOR 2023
Retractable Technologies, Inc. reported a significant decrease in revenues for the fiscal year ending December 31, 2023, with a 54% drop largely attributed to declining demand for COVID-19 vaccination products. Domestic and international revenues faced substantial reductions, leading to an operating loss of $11.5 million. Although the company maintains adequate liquidity and is investing in product development, the challenges posed by reduced sales and higher operational costs indicate a difficult period ahead. The annual results are discussed in further detail in their Form 10-K filed with the SEC.
Read more →RVP▲ +5.3%on this news
The Long, Productive Career of an Advocate for Nurses: Claire M. Fagin
Claire Fagin, a prominent figure in nursing, passed away at 97, leaving a legacy of advocacy and innovation. Her career included challenging hospital visiting policies and promoting higher education standards for nurses. Fagin authored influential works addressing healthcare issues and dedicated her life to serving others in the nursing community.
Read more →RVP▲ +5.3%on this newsshared move
The University of North Texas Launches a New Nursing Program
The University of North Texas has launched a new nursing program to address the increasing demand for registered nurses in the Dallas-Fort Worth area. Approved in 2023, the program will offer BSN and MSN degrees starting in fall 2024. The initiative aims to mitigate the projected nursing shortage in Texas, exacerbated by factors such as burnout from the COVID-19 pandemic. Dr. Cindy Weston has been appointed as the founding dean to lead this effort.
Read more →RVP▲ +5.3%on this newsshared move
Texas Woman’s University Has Begun Construction of a Health Sciences Center in Denton
Texas Woman’s University has commenced construction on a $107 million health sciences center in Denton, Texas. The 136,000-square-foot facility will enhance training for nursing, physical therapy, and occupational therapy students, particularly for rural healthcare roles. Expected to open in fall 2025, it aims to increase the number of graduates by 30%. This project aligns with a $125 million fundraising campaign.
Read more →RVPClimate Change: A Serious and Pressing Challenge
The National Climate Assessment warns that climate change is a pressing issue affecting healthcare. Nurses, facing burnout and increased demands, are stepping up to address these challenges. Organizations like the Alliance of Nurses for Healthy Environments are advocating for environmental health. Despite public division on climate change, nurses' high trust levels position them to influence dialogue and policy change.
Read more →RVPRetractable Technologies, Inc. Then & Now
Retractable Technologies, Inc. (RTI) has evolved significantly since its incorporation in 1994, focusing on the development of retractable safety needle devices. The company has expanded its product offerings and manufacturing capabilities while advocating for safety needle legislation. Notably, RTI supported the U.S. vaccination efforts during the COVID-19 pandemic by providing over 1.2 billion syringes. The company continues to be a leader in safety syringe technology.
Read more →RVPSafety Communication from FDA Is Not Related to Vanishpoint® Syringe
Retractable Technologies Inc. clarified that the recent FDA Safety Communication regarding plastic syringes does not pertain to their VanishPoint safety syringes. The FDA's communication highlighted quality issues with syringes made in China, but Retractable Technologies confirmed that their products remain unchanged and safe. Users can continue to trust VanishPoint syringes for accurate dosing and protection against needlesticks.
Read more →RVPRetractable Technologies, Inc. Not Impacted by FDA Safety Communication
Retractable Technologies, Inc. has announced that it is not affected by the FDA's recent Safety Communication regarding potential device failures in plastic syringes made in China. The FDA's communication cited quality issues, but Retractable confirmed that its VanishPoint Safety Syringe has not undergone any design changes that would affect safety. This reassures users of the syringe's reliability in delivering precise medication doses and improving user safety against needlesticks.
Read more →RVPRETRACTABLE TECHNOLOGIES, INC. RESULTS FOR THE PERIODS ENDED SEPTEMBER 30, 2023
Retractable Technologies, Inc. reported significant financial losses for the periods ending September 30, 2023. The company recorded an operating loss of $8.7 million for the first nine months of the year, a stark contrast to an operating income of $7.0 million during the same period in 2022. Total net sales fell to $10.3 million in the third quarter, affected by reduced sales linked to COVID-19 vaccination efforts and a dramatic decline in international sales. Additionally, unrealized losses on investments further compounded the company's financial challenges.
Read more →RVPRETRACTABLE TECHNOLOGIES, INC. RESULTS FOR THE PERIOD ENDED JUNE 30, 2023
Retractable Technologies, Inc. reported significant declines in sales and increased operating losses for the second quarter of 2023 compared to the same period last year. Total net sales were $8.0 million, down from $14.3 million, while the operating loss grew to $5.0 million. The company attributed these disappointments to lower demand, particularly from U.S. government orders related to COVID-19 vaccination efforts. Despite increased investments in marketing and sales, the company's financial challenges and overall decrease in revenues present a concerning outlook.
Read more →RVPRETRACTABLE TECHNOLOGIES, INC. RESULTS FOR THE PERIOD ENDED MARCH 31, 2023
Retractable Technologies, Inc. reported a drastic decline in financial performance for the first quarter of 2023, with total net sales dropping to $11.0 million from $44.7 million in the same quarter last year. The company faced an operating loss of $2.7 million, contrasting starkly with the previous year's operating income of $9.7 million, largely due to the absence of syringe sales to the U.S. government related to COVID-19 vaccinations. Although investment in sales and marketing increased, the lack of domestic and international demand has significantly affected revenue and overall unit sales. The results indicate serious challenges for company revenues moving forward, compared to robust sales in previous years fueled by government orders.
Read more →RVPRETRACTABLE TECHNOLOGIES, INC. REPORTS RESULTS FOR 2022
Retractable Technologies, Inc. reported a significant decline in overall revenues for 2022, decreasing by 49.7% primarily due to a reduction in U.S. government orders for COVID-19 vaccinations. While international sales surged, domestic demand suffered greatly, leading to a marked drop in earnings and operational losses. The company also incurred substantial operating expenses related to stock options, impacting overall profitability. Despite these financial challenges, advances in facility expansions funded by TIA reimbursements indicate ongoing investment in future capabilities.
Read more →RVPRETRACTABLE TECHNOLOGIES, INC. RESULTS FOR THE PERIODS ENDED SEPTEMBER 30, 2022
RETRACTABLE TECHNOLOGIES, INC. RESULTS FOR THE PERIODS ENDED SEPTEMBER 30, 2022 LITTLE ELM, TEXAS, November 14, 2022 - Retractable Technologies, Inc. (NYSE American: RVP) reports that its operating income was $7.0 million for the first nine months of 2022 and that it had an o
Read more →RVPRETRACTABLE TECHNOLOGIES, INC. RESULTS FOR THE PERIODS ENDED JUNE 30, 2022
RETRACTABLE TECHNOLOGIES, INC. RESULTS FOR THE PERIODS ENDED JUNE 30, 2022 LITTLE ELM, TEXAS, August 15, 2022 - Retractable Technologies, Inc. (NYSE American: RVP) reports that its operating income was $7.7 million for the first six months of 2022 and that it had an operating
Read more →RVP▼ -5.2%on this news
RETRACTABLE TECHNOLOGIES, INC. REPORTS $9.7 MILLION IN OPERATING INCOME FOR THE FIRST THREE MONTHS OF 2022
RETRACTABLE TECHNOLOGIES, INC. REPORTS $9.7 MILLION IN OPERATING INCOME FOR THE FIRST THREE MONTHS OF 2022 LITTLE ELM, TEXAS, May 17, 2022 - Retractable Technologies, Inc. (NYSE American: RVP) reports that its operating income was $9.7 million for the first three months of 202
Read more →RVPRETRACTABLE TECHNOLOGIES, INC. REPORTS RESULTS FOR 2021
RETRACTABLE TECHNOLOGIES, INC. REPORTS LITTLE ELM, Texas, March 31, 2022-Retractable Technologies, Inc. (NYSE American: RVP) reports the following information relating to the year ended December 31, 2021. Further details concerning the results of operations as well as other ma
Read more →RVP▼ -6.3%on this news
RETRACTABLE TECHNOLOGIES, INC. REPORTS $44.1 MILLION IN OPERATING INCOME FOR THE FIRST NINE MONTHS OF 2021
RETRACTABLE TECHNOLOGIES, INC. REPORTS $44.1 MILLION IN OPERATING INCOME FOR THE FIRST NINE MONTHS OF 2021 LITTLE ELM, TEXAS, November 16, 2021 - Retractable Technologies, Inc. (NYSE American: RVP) reports that its operating income was $44.1 million for the first nine months
Read more →RVP▼ -5.3%on this news
RETRACTABLE TECHNOLOGIES, INC. DECLARES DIVIDENDS TO SERIES II CLASS B
RETRACTABLE TECHNOLOGIES, INC. DECLARES DIVIDENDS TO SERIES II CLASS B CONVERTIBLE PREFERRED STOCK SHAREHOLDERS LITTLE ELM, Texas, September 30, 2021-Retractable Technologies, Inc. (NYSE American: RVP) announced today that its Board of Directors has declared dividends to hold
Read more →RVP▼ -12.6%on this news
RETRACTABLE TECHNOLOGIES, INC. REPORTS $36.1 MILLION IN OPERATING INCOME FOR THE FIRST SIX MONTHS OF 2021
RETRACTABLE TECHNOLOGIES, INC. REPORTS $36.1 MILLION IN OPERATING INCOME FOR THE FIRST SIX MONTHS OF 2021 LITTLE ELM, TEXAS, August 17, 2021 - Retractable Technologies, Inc. (NYSE American: RVP) reports that its operating income was $36.1 million for the first six months of 2
Read more →RVPRETRACTABLE TECHNOLOGIES, INC. REPORTS $23.4 MILLION IN OPERATING INCOME FOR FIRST QUARTER OF 2021
RETRACTABLE TECHNOLOGIES, INC. REPORTS $23.4 MILLION IN OPERATING INCOME FOR FIRST QUARTER OF 2021 LITTLE ELM, Texas, May 17, 2021-Retractable Technologies, Inc. (NYSE American: RVP) reports that its operating income was $23.4 million in the first quarter of 2021, compared t
Read more →RVPRETRACTABLE TECHNOLOGIES, INC. REPORTS RESULTS FOR 2020
RETRACTABLE TECHNOLOGIES, INC. REPORTS LITTLE ELM, Texas, April 1, 2021-Retractable Technologies, Inc. (NYSE American: RVP) reports the following information relating to the year ended December 31, 2020. Further details concerning the results of operations as well as other mat
Read more →RVPRETRACTABLE TECHNOLOGIES, INC. DECLARES DIVIDENDS TO SERIES I AND II CLASS B
RETRACTABLE TECHNOLOGIES, INC. DECLARES DIVIDENDS TO SERIES I AND II CLASS B CONVERTIBLE PREFERRED STOCK SHAREHOLDERS LITTLE ELM, Texas, January 8, 2021-Retractable Technologies, Inc. (NYSE American: RVP) announced today that its Board of Directors has declared dividends to ho
Read more →RVPRETRACTABLE TECHNOLOGIES, INC. REPORTS INCREASED INCOME AND SALES FOR THIRD QUARTER OF 2020
RETRACTABLE TECHNOLOGIES, INC. REPORTS INCREASED INCOME AND SALES FOR THIRD QUARTER OF 2020 LITTLE ELM, TEXAS, November 18, 2020 - Retractable Technologies, Inc. (NYSE American: RVP) reports that its operating income was $10.3 million in the third quarter of 2020, compared to
Read more →RVPRETRACTABLE TECHNOLOGIES, INC. REPORTS INCREASED INCOME AND SALES FOR SECOND QUARTER OF 2020
RETRACTABLE TECHNOLOGIES, INC. REPORTS INCREASED INCOME AND SALES FOR SECOND QUARTER OF 2020 LITTLE ELM, TEXAS, August 17, 2020 - Retractable Technologies, Inc. (NYSE American: RVP) reports that its operating income was $960 thousand in the second quarter of 2020, compared to
Read more →RVPRETRACTABLE TECHNOLOGIES, INC. REPORTS OPERATING INCOME AND INCREASED SALES FOR FIRST QUARTER OF 2020
RETRACTABLE TECHNOLOGIES, INC. REPORTS OPERATING INCOME AND INCREASED SALES FOR FIRST QUARTER OF 2020 LITTLE ELM, Texas, May 18, 2020-Retractable Technologies, Inc. (NYSE American: RVP) reports that its operating income was $481 thousand in the first quarter of 2020, compared
Read more →RVPRETRACTABLE TECHNOLOGIES, INC. REPORTS RESULTS FOR 2019
RETRACTABLE TECHNOLOGIES, INC. REPORTS LITTLE ELM, Texas, March 31, 2020-Retractable Technologies, Inc. (NYSE American: RVP) reports the following information relating to the year ended December 31, 2019. Further details concerning the results of operations as well as other ma
Read more →RVPRETRACTABLE TECHNOLOGIES, INC. REPORTS OPERATING INCOME AND INCREASED SALES FOR THIRD QUARTER 2019
RETRACTABLE TECHNOLOGIES, INC. REPORTS OPERATING INCOME AND INCREASED SALES FOR THIRD QUARTER 2019 LITTLE ELM, Texas, November 15, 2019 Retractable Technologies, Inc. (NYSE American: RVP) reports that its operating income was $978 thousand in the third quarter of 2019, compared
Read more →RVPRETRACTABLE TECHNOLOGIES, INC. REPORTS OPERATING INCOME AND INCREASED SALES FOR SECOND QUARTER 2019
RETRACTABLE TECHNOLOGIES, INC. REPORTS OPERATING INCOME AND INCREASED SALES FOR SECOND QUARTER 2019 LITTLE ELM, Texas, August 15, 2019 Retractable Technologies, Inc. (NYSE American: RVP) reports that its operating income was $329 thousand in the second quarter of 2019, compared
Read more →RVPRETRACTABLE TECHNOLOGIES, INC. ANNOUNCES RESULTS AS OF MARCH 31, 2019
RETRACTABLE TECHNOLOGIES, INC. ANNOUNCES RESULTS AS OF MARCH 31, 2019 LITTLE ELM, TEXAS, May 15, 2019 Retractable Technologies, Inc. (NYSE American: RVP) reports the following results of operations for the three months ended March 31, 2019 as compared to results for the same per
Read more →RVPRETRACTABLE TECHNOLOGIES, INC. REPORTS RESULTS FOR THE YEAR 2018
RETRACTABLE TECHNOLOGIES, INC. REPORTS RESULTS FOR THE YEAR 2018 LITTLE ELM, Texas, March 29, 2019 Retractable Technologies, Inc. (NYSE American: RVP) reports the following information relating to the year ended December 31, 2018. Further details concerning the results of operat
Read more →RVPRetractable Technologies, Inc. Announces Results as of
Retractable Technologies, Inc. Announces Results as of September 30, 2018 LITTLE ELM, Texas, November 15, 2018 Retractable Technologies, Inc. (NYSE American: RVP) reports the following results of operations for the three and nine months ended September 30, 2018 as compared to re
Read more →RVPRetractable Technologies, Inc. Reports Results as of
Retractable Technologies, Inc. Reports Results as of June 30, 2018 LITTLE ELM, Texas, August 14, 2018 Retractable Technologies, Inc. (NYSE American: RVP) reports the following results of operations for the three and six months ended June 30, 2018 and 2017, respectively. Retracta
Read more →RVPwww.vanishpoint.com rti@vanishpoint.com P.O. Box 9, 511 Lobo Lane, Little Elm, Texas 75068-0009 Tel: (972) 294-1010 - Fax: (972) 292-3600 - Toll Free: (888)806-2626
Enclosed is the Form 10-K of Retractable Technologies, Inc. Key developments since January 1, 2017 include: Domestic sales, which accounted for 78.3% of the revenues in 2017, increased 2.7%, principally due to increased sales of EasyPoint and the blood collection set. Internatio
Read more →RVPRetractable Technologies, Inc. Reports Results for the Year 2017
Retractable Technologies, Inc. Reports Results for the Year 2017 LITTLE ELM, Texas, April 2, 2018 Retractable Technologies, Inc. (NYSE American: RVP) reports the following results of operations for the twelve months ended December 31, 2017 and 2016, respectively. Domestic sales
Read more →RVPEastern District Court Denies Motion to Reconsider Becton, Dickinson and Co. Judgment
Eastern District Court Denies Motion to Reconsider Becton, Dickinson and Co. Judgment LITTLE ELM, Texas, October 31, 2017 Retractable Technologies, Inc. (NYSE American: RVP), ( RTI ) reports that on October 27, 2017, the United States District Court for the Eastern District of T
Read more →RVPExhi bit 99 Retractable Technologies, Inc. Files Motions in Connection with Becton, Dickinson and Co. Judgment
Retractable Technologies, Inc. Files Motions in Connection with Becton, Dickinson and Co. Judgment LITTLE ELM, Texas, September 15, 2017 Retractable Technologies, Inc. (NYSE American: RVP), ( RTI ) reports that on September 13, 2017, it filed a Motion to Alter or Amend the Judgm
Read more →RVPRetractable Technologies, Inc. Reports Sale of Common Stock
Retractable Technologies, Inc. Reports Sale of Common Stock LITTLE ELM, Texas, August 24, 2017 Retractable Technologies, Inc. (NYSE American: RVP), ( RTI ) reports that on August 23, 2017, RTI issued and sold to Thomas J. Shaw, its founder, President, Chief Executive Officer, an
Read more →RVPDistrict Court Issues Final Judgment - Retractable Technologies, Inc., et. al. v. Becton, Dickinson and Co.
District Court Issues Final Judgment - Retractable Technologies, Inc., et. al. v. Becton, Dickinson and Co. LITTLE ELM, Texas, August 18, 2017 Retractable Technologies, Inc. (NYSE American: RVP), ( RTI ) reports that on August 17, 2017, Judge Amos L. Mazzant of the United States
Read more →RVPRetractable Technologies, Inc. Announces Litigation Update and Results for the First Quarter of 2017
Retractable Technologies, Inc. Announces Litigation Update and Results for the First Quarter of 2017 LITTLE ELM, Texas, May 15, 2017 Retractable Technologies, Inc. (NYSE MKT: RVP) announced today that the bench trial in the case of Retractable Technologies, Inc. v. Becton, Dicki
Read more →RVPRetractable Technologies, Inc. Reports Results for the Year 2016
Retractable Technologies, Inc. Reports Results for the Year 2016 LITTLE ELM, Texas, April 3, 2017 Retractable Technologies, Inc. (NYSE MKT: RVP) reports the following results of operations for the twelve months ended December 31, 2016 and 2015, respectively. Domestic sales acco
Read more →RVPRetractable Technologies, Inc. Announces Litigation Updates
Retractable Technologies, Inc. Announces Litigation Updates LITTLE ELM, Texas, March 21, 2017 Retractable Technologies, Inc. (NYSE MKT: RVP) announced today that the U.S. Supreme Court denied its petition for a writ of certiorari to review the December 2, 2016 Fifth Circuit Cour
Read more →RVPRetractable Technologies, Inc. Reports on Fifth Circuit's Opinion
Retractable Technologies, Inc. Reports on Fifth Circuit's Opinion LITTLE ELM, Texas, December 6, 2016 On Friday, December 2, the Fifth Circuit Court of Appeals overturned a district court judgment that had previously awarded Retractable Technologies, Inc. [NYSE MKT: RVP] ( RTI )
Read more →RVPRetractable Technologies, Inc. Reports Results for the First Quarter of 2016 Little Elm, Texas
Retractable Technologies, Inc. Reports Results for the First Quarter of 2016 Little Elm, Texas, May 17, 2016 Retractable Technologies, Inc. (NYSE MKT: RVP) reported the following results of operations for the first quarter of 2016 and other matters in its quarterly report on For
Read more →RVPRetractable Technologies, Inc. Reports Results for the Year 2015 Little Elm, Texas
Retractable Technologies, Inc. Reports Results for the Year 2015 Little Elm, Texas, April 1, 2016 Retractable Technologies, Inc. (NYSE MKT: RVP) reports the following results of operations for the twelve months ended December 31, 2015 and 2014, respectively. Comparison of Year
Read more →RVPOral Argument Calendared for Retractable Technologies, Inc.
Oral Argument Calendared for Retractable Technologies, Inc. LITTLE ELM, Texas, January 28, 2016 Retractable Technologies, Inc. (NYSE MKT: RVP) reports that oral argument before the United States Court of Appeals for the Fifth Circuit has been set on the Court s calendar for Mond
Read more →RVPRetractable Technologies, Inc. Reports Results for the Third Quarter of 2015
Retractable Technologies, Inc. Reports Results for the Third Quarter of 2015 LITTLE ELM, Texas, November 17, 2015 Retractable Technologies, Inc. (NYSE MKT: RVP) reports the following results of operations for the three and nine months ended September 30, 2015 and 2014, respectiv
Read more →RVPRetractable Technologies, Inc. Reports Recognition of Payment
Retractable Technologies, Inc. Reports Recognition of Payment LITTLE ELM, Texas, May 21, 2015 Retractable Technologies, Inc. (NYSE MKT: RVP) ( RTI ) reports that in the second quarter of 2015, RTI will record as income and remove from RTI s current liabilities, the $7,724,826 ju
Read more →RVPRetractable Technologies, Inc. Reports Improved Results for the First Quarter 2015
Retractable Technologies, Inc. Reports Improved Results for the First Quarter 2015 LITTLE ELM, Texas, May 15, 2015 Retractable Technologies, Inc. (NYSE MKT: RVP) reports the following results of operations for the three months ended March 31, 2015 and 2014, respectively. Compar
Read more →RVPRetractable Technologies, Inc. Reports Results for the Three and Twelve Months Ended
Retractable Technologies, Inc. Reports Results for the Three and Twelve Months Ended December 31, 2014 LITTLE ELM, Texas, April 1, 2015 Retractable Technologies, Inc. (NYSE MKT: RVP) reports the following results of operations for the three and twelve months ended December 31, 2
Read more →RVPCourt of Appeals Order Retractable Technologies, Inc., et al., v. Becton, Dickinson and Co.
Court of Appeals Order Retractable Technologies, Inc., et al., v. Becton, Dickinson and Co. LITTLE ELM, Texas, February 5, 2015 Retractable Technologies, Inc. (NYSE MKT: RVP) ( RTI ) announced today that on February 3, 2015 the United States Court of Appeals for the Fifth Circui
Read more →RVPRetractable Technologies, Inc. Reports Quarterly Profits
Retractable Technologies, Inc. Reports Quarterly Profits LITTLE ELM, Texas, November 17, 2014 Retractable Technologies, Inc. (NYSE MKT: RVP) reports the following results of operations for the three and nine months ended September 30, 2014 and 2013, respectively. Our third quar
Read more →RVPDistrict Court Issues Order Granting Retractable Technologies, Inc. Injunctive Relief Under the Lanham Act
District Court Issues Order Granting Retractable Technologies, Inc. Injunctive Relief Under the Lanham Act LITTLE ELM, Texas, November 13, 2014 Retractable Technologies, Inc. (NYSE MKT: RVP), ( RTI ) announced today that Judge Leonard Davis of the United States District Court fo
Read more →RVPDistrict Court Issues Order Denying Becton, Dickinson and Company s Renewed Motion for Judgment as a Matter of Law Against Retractable Technologies, Inc.
District Court Issues Order Denying Becton, Dickinson and Company s Renewed Motion for Judgment as a Matter of Law Against Retractable Technologies, Inc. LITTLE ELM, Texas, October 6, 2014 Retractable Technologies, Inc. (NYSE MKT: RVP), ( RTI ) announced today that Judge Leonard
Read more →RVPRetractable Technologies, Inc. Reports Results of Operations
Retractable Technologies, Inc. Reports Results of Operations LITTLE ELM, Texas, August 14, 2014 Retractable Technologies, Inc. (NYSE MKT: RVP) reports the following results of operations for the three and six months ended June 30, 2014 and 2013, respectively. Comparison of Thre
Read more →RVPRetractable Technologies, Inc. Announces Verdict
Retractable Technologies, Inc. Announces Verdict LITTLE ELM, Texas, September 19, 2013 Retractable Technologies, Inc. (NYSE MKT: RVP), a leading maker of safety medical devices, announced today that a Tyler, Texas jury returned a verdict in the litigation of Retractable Technolo
Read more →RVPRetractable Technologies, Inc. s Unit Sales Jumped in the Third Quarter of 2012
Retractable Technologies, Inc. s Unit Sales Jumped in the Third Quarter of 2012 LITTLE ELM, Texas, November 15, 2012 Retractable Technologies, Inc. (NYSE MKT: RVP) reported an overall unit sales increase of 54.7% for the third quarter of 2012, compared to the third quarter of 20
Read more →RVPRetractable Technologies, Inc. s Gross Profit Increased 6.2% In the Second Quarter of 2012 Over the Second Quarter of 2011
Retractable Technologies, Inc. s Gross Profit Increased 6.2% In the Second Quarter of 2012 Over the Second Quarter of 2011 LITTLE ELM, Texas, August 15, 2012 Retractable Technologies, Inc. (NYSE MKT: RVP) reported a 6.2% increase in gross profit for the three months ended June 3
Read more →RVPRetractable Technologies, Inc. Launches New VanishPoint Blood Collection Set
Retractable Technologies, Inc. Launches New VanishPoint Blood Collection Set LITTLE ELM, Texas, July 26, 2012 Retractable Technologies, Inc. (NYSE MKT: RVP) announced today the launch of a new innovative product, the VanishPoint Blood Collection Set (BCS). Studies have shown th
Read more →RVPRetractable Technologies, Inc. Reports Lower Revenue for the First Quarter
Retractable Technologies, Inc. Reports Lower Revenue for the First Quarter LITTLE ELM, Texas, May 16, 2012 Retractable Technologies, Inc. (NYSE AMEX: RVP), a leading maker of safety medical devices, reported an operating loss of $645 thousand for the three months ended March 31,
Read more →RVPRetractable Technologies, Inc. states that its policy is not to comment on unusual market activity
Retractable Technologies, Inc. states that its policy is not to comment on unusual market activity LITTLE ELM, Texas April 25, 2012 In view of the unusual market activity in the common stock of Retractable Technologies, Inc. (NYSE Amex: RVP), the NYSE has contacted the company i
Read more →RVPRetractable Technologies, Inc. Decreased Its Loss from Operations Dramatically for the Nine Months Ended
Retractable Technologies, Inc. Decreased Its Loss from Operations Dramatically for the Nine Months Ended September 30, 2011 LITTLE ELM, Texas, November 29, 2011 Retractable Technologies, Inc. (NYSE AMEX: RVP), a leading maker if safety medical devices, reported an operating loss
Read more →RVPRetractable Technologies, Inc. s Unit Sales Increased Dramatically in the Second Quarter of 2011 Over the Second Quarter of 2010
Retractable Technologies, Inc. s Unit Sales Increased Dramatically in the Second Quarter of 2011 Over the Second Quarter of 2010 LITTLE ELM, Texas, August 15, 2011 Retractable Technologies, Inc. (NYSE AMEX: RVP), a leading maker of safety medical devices, reported an overall uni
Read more →RVPRetractable Technologies, Inc. Reports Net Income of $1.7 Million for the First Quarter of 2011
Retractable Technologies, Inc. Reports Net Income of $1.7 Million for the First Quarter of 2011 LITTLE ELM, Texas, May 20, 2011 Retractable Technologies, Inc. (NYSE AMEX: RVP), a leading maker of safety medical devices, reported net income of $1,723,957 for the first quarter of
Read more →RVPRetractable Technologies, Inc. s Normal Policy Is Not to Comment on Unusual Market Activity
Retractable Technologies, Inc. s Normal Policy Is Not to Comment on Unusual Market Activity LITTLE ELM, Texas April 25, 2011 In view of the unusual market activity in the common stock of Retractable Technologies, Inc. (NYSE AMEX:RVP) on April 25, 2011, the NYSE has contacted us
Read more →RVPRetractable Technologies, Inc. Reports Net Income of $2.4 Million in 2010
Retractable Technologies, Inc. Reports Net Income of $2.4 Million in 2010 LITTLE ELM, Texas April 6, 2011 Retractable Technologies, Inc. ( Retractable ) (NYSE AMEX: RVP), a leading maker of safety needle devices, announces net income of more than $2.4 million in 2010 compared to
Read more →RVPRetractable Technologies, Inc. Reports 77% Gross Profit Increase for Q3 2010
Technologies, Inc. Reports 77% Gross Profit Increase for Q3 2010 ELM, Texas, December 2, 2010 Retractable Technologies, Inc. ( Retractable ) (NYSE AMEX: RVP), a leading maker of safety medical devices, reported a gross profit of $5.2 million for the three months ended Septembe
Read more →RVPRetractable Technologies, Inc. Reports 61.0% Sales Increase for the First Quarter of 2010
Technologies, Inc. Reports 61.0% Sales Increase for the First Quarter of ELM, Texas, May 19, 2010 Retractable Technologies, Inc. (NYSE AMEX: RVP), a leading maker of safety medical devices, reported net sales of $8.5 million for the three months ended March 31, 2010, a 61% inc
Read more →RVPRetractable Technologies, Inc. Reports an Increase in Revenues of 39.7% for 2009
Technologies, Inc. Reports an Increase in Revenues of 39.7% for 2009 LITTLE ELM, Texas April 7, 2010 Retractable Technologies, Inc. ( Retractable ) (NYSE AMEX: RVP), a leading maker of safety needle devices, announced an increase in revenues of 39.7% for the year 2009 over 20
Read more →RVPCourt Issues Permanent Injunction Enjoining OMI from Infringing a Retractable Technologies, Inc. Syringe Patent
Issues Permanent Injunction Enjoining OMI from Infringing a Retractable Technologies, Inc. Syringe Patent LITTLE ELM, Texas March 5, 2010 Retractable Technologies, Inc. ( Retractable ) (AMEX: RVP), a leading maker of safety needle devices, announced that a final judgment and
Read more →RVPRetractable Technologies, Inc. Announces Verdict in Patent Infringement Suit
Retractable Technologies, Inc. Announces Verdict in Patent Infringement Suit ELM, Texas December 23, 2009 Retractable Technologies, Inc. ( Retractable ) (AMEX: RVP), a leading maker of safety needle devices, announced today that a Tyler, Texas jury returned a verdict on Frida
Read more →RVPRetractable Technologies, Inc. Has 3Q 2009 Revenues Increase 19.5 Percent Over 3Q 2008
Technologies, Inc. Has 3Q 2009 Revenues Increase 19.5 Percent Over 3Q 2008 LITTLE ELM, Texas, November 19, 2009 Retractable Technologies, Inc. (the Company ) (AMEX: RVP), a leading maker of safety needle medical devices, reported revenues of $10.8 million for the three months
Read more →RVPRetractable Technologies, Inc. Acts to Reduce Annual Operating Expenses by $6 Million
Retractable Technologies, Inc. Acts to Reduce Annual Operating Expenses by $6 Million LITTLE ELM, Texas June 30, 2009 Retractable Technologies, Inc. (AMEX: RVP), a leading maker of safety needle devices, continues to experience significant barriers against our efforts to esta
Read more →RVPRETRACTABLE TECHNOLOGIES, INC. REPORTS FIRST HALF 2008 SALES OF $11.8
TECHNOLOGIES, INC. REPORTS FIRST HALF 2008 SALES OF $11.8 MILLION LITTLE ELM, Texas, August 11, 2008 Retractable Technologies, Inc. (AMEX: RVP), a leading maker of safety needle devices, reports sales of $11.8 million for the six months ended June 30, 2008. Sales for the three
Read more →RVPRETRACTABLE TECHNOLOGIES, INC. REPORTS FIRST QUARTER 2008 SALES OF $5.3
TECHNOLOGIES, INC. REPORTS FIRST QUARTER 2008 SALES OF $5.3 MILLION LITTLE ELM, Texas, May 15, 2008 Retractable Technologies, Inc. (AMEX: RVP), a leading maker of safety needle devices, today reported revenues of $5.3 million for the three months ended March 31, Domestic sale
Read more →RVPRetractable Technologies, Inc. Reports 2007 Sales of $26.3 Million, New Patent, and Recent Litigation Matters
Retractable Technologies, Inc. Reports 2007 Sales of $26.3 Million, New Patent, and Recent Litigation Matters ELM, Texas, April 3, 2008 Retractable Technologies, Inc. (AMEX: RVP), a leading maker of safety needle devices, today reported revenues of $26.3 increased due princip
Read more →RVPRETRACTABLE TECHNOLOGIES, INC. REPORTS NINE MONTHS 2007 SALES OF $19.1
TECHNOLOGIES, INC. REPORTS NINE MONTHS 2007 SALES OF $19.1 MILLION LITTLE ELM, Texas, November 16, 2007 Retractable Technologies, Inc. (AMEX: RVP), a leading maker of safety needle devices, today reported revenues of $8.0 million and $19.1 million for the three and nine months
Read more →RVPRETRACTABLE TECHNOLOGIES, INC. REPORTS FIRST HALF 2007 SALES OF $11.0 MILLION AS UNIT SALES RISE 9.2%
RETRACTABLE TECHNOLOGIES, INC. REPORTS FIRST HALF 2007 SALES OF $11.0 MILLION AS UNIT SALES RISE 9.2% ELM, Texas, August 15, 2007 Retractable Technologies, Inc. (AMEX: RVP), a leading maker of safety needle devices, today reported revenues of $5.3 million and $11.0 million fo
Read more →RVPCase 2:07-cv-00250-DF Document 1-1 Filed 06/15/2007 Page 1 of 31 IN THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF TEXAS MARSHALL DIVISION RETRACTABLE TECHNOLOGIES, INC., Plaintiff, CIVIL ACTION NO. 2:07-cv
2:07-cv-00250-DF Document 1-1 Filed 06/15/2007 Page 1 of 31 IN THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF TEXAS RETRACTABLE TECHNOLOGIES, INC., Plaintiff, CIVIL ACTION NO. 2:07-cv-250 (FOLSOM) v. BECTON DICKINSON AND COMPANY, JURY TRIAL DEMANDED
Read more →RVPRETRACTABLE TECHNOLOGIES, INC. REPORTS $5.8 MILLION IN FIRST QUARTER REVENUES AS UNIT SALES INCREASE 61.5%
RETRACTABLE TECHNOLOGIES, INC. REPORTS $5.8 MILLION IN FIRST QUARTER REVENUES AS UNIT SALES INCREASE 61.5% ELM, Texas, May 16, 2007 Retractable Technologies, Inc. (AMEX: RVP), a leading maker of safety needle devices, today reported revenues of $5.8 million for the three mont
Read more →RVPRETRACTABLE TECHNOLOGIES, INC. ANNOUNCES RECORD 2006 REVENUES OF $25.3 MILLION ON 32.6%
TECHNOLOGIES, INC. ANNOUNCES RECORD 2006 REVENUES OF $25.3 MILLION ON 32.6% LITTLE ELM, Texas, April 10, 2007 Retractable Technologies, Inc. (AMEX: RVP), a leading maker of safety needle devices, today reported record total revenues of $25.3 million for the year ended December
Read more →RVPQUEENSLAND
QUEENSLAND, AUSTRALIA HEALTH SYSTEM AWARDS RETRACTABLE TECHNOLOGIES SAFETY NEEDLE CONTRACT LITTLE ELM, TEXAS, March 7, 2007-Retractable Technologies, Inc. (AMEX: RVP), a leading maker of safety needle devices, announced today that Queensland Health, a department within the Quee
Read more →RVPU. S. GOV T AWARDS RETRACTABLE TECHNOLOGIES THIRD SAFETY SYRINGE CONTRACT UNDER BUSH GLOBAL HIV/AIDS INITIATIVE LITTLE ELM, TEXAS, Feb. 15th, 2007-Retractable Technologies, Inc. (AMEX: RVP) announce
U. S. GOV T AWARDS RETRACTABLE TECHNOLOGIES THIRD SAFETY SYRINGE CONTRACT UNDER BUSH GLOBAL HIV/AIDS LITTLE ELM, TEXAS, Feb. 15th, 2007-Retractable Technologies, Inc. (AMEX: RVP) announced today that it has been awarded its third major U.S. government contract to provide Vanish
Read more →RVPRETRACTABLE TECHNOLOGIES, INC. REPORTS 30.1
RETRACTABLE TECHNOLOGIES, INC. REPORTS 30.1 PERCENT INCREASE IN SALES IN THE FIRST QUARTER LITTLE ELM, TX May 17, 2006 Retractable Technologies, Inc. (AMEX:RVP), a leading maker of safety needle devices, today reported $5.5 million in total sales for the three months ended Marc
Read more →RVPRETRACTABLE TECHNOLOGIES, INC. POSTS RECORD 4 th QUARTER, FULL-YEAR 2005 SALES AND $316,000 4 th
RETRACTABLE TECHNOLOGIES, INC. POSTS RECORD 4th QUARTER, FULL-YEAR 2005 SALES AND $316,000 4th QUARTER NET INCOME LITTLE ELM, TX, April 3, 2006 Retractable Technologies, Inc. (AMEX: RVP), a leading maker of safety needle devices, today reported net income of $316,000 for the th
Read more →RVPWednesday November 16, 9:00 am ET FOR IMMEDIATE RELEASE RETRACTABLE TECHNOLOGIES, INC. POSTS $27,621 IN 3 rd QUARTER NET INCOME ON HIGHER U. S. UNIT SALES
Wednesday November 16, 9:00 am ET RETRACTABLE TECHNOLOGIES, INC. POSTS $27,621 IN 3rd QUARTER NET INCOME ON HIGHER U. S. UNIT SALES, IMPROVED PROFIT MARGINS LITTLE ELM, TX, November 16, 2005 Retractable Technologies, Inc. (AMEX: RVP), a leading maker of safety needle devices,
Read more →RVPU. S. GOV T AWARDS RETRACTABLE TECHNOLOGIES SECOND SAFETY SYRINGE CONTRACT UNDER BUSH GLOBAL HIV/AIDS
U. S. GOV T AWARDS RETRACTABLE TECHNOLOGIES SECOND SAFETY SYRINGE CONTRACT UNDER BUSH GLOBAL HIV/AIDS INITIATIVE LITTLE ELM, TEXAS, Nov. 2, 2005-Retractable Technologies, Inc. (AMEX: RVP) announced today that it has been awarded its second major U.S. government contract to prov
Read more →Competitive Position
How RVP ranks across every disease it competes inCompetitive Position is a premium feature
See how RVP ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trial